Resveratoral Protects Against Angiotensin II-Induced Cellular Hypertrophy through Inhibition of CYP1B1/Mid-Chain Hydroxyeicosatetraenoic Acid Mechanism

被引：0
|
作者：
Shoieb, Sherif M. [1 ]
El-Kadi, Ayman O. S. [1 ]
机构：
[1] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB, Canada
来源：
FASEB JOURNAL | 2019年 / 33卷
基金：
加拿大健康研究院;
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
817.3
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Resveratrol attenuates angiotensin II-induced cellular hypertrophy through the inhibition of CYP1B1 and the cardiotoxic mid-chain HETE metabolites
    Shoieb, Sherif M.
    El-Kadi, Ayman O. S.
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2020, 471 (1-2) : 165 - 176
  • [2] Resveratrol attenuates angiotensin II-induced cellular hypertrophy through the inhibition of CYP1B1 and the cardiotoxic mid-chain HETE metabolites
    Sherif M. Shoieb
    Ayman O. S. El-Kadi
    Molecular and Cellular Biochemistry, 2020, 471 : 165 - 176
  • [3] Inhibition of Mid-chain HETEs Protects Against Angiotensin II-induced Cardiac Hypertrophy
    Elkhatali, Samya
    Maayah, Zaid H.
    El-Sherbeni, Ahmed A.
    Elshenawy, Osama H.
    Abdelhamid, Ghada
    Shoieb, Sherif M.
    El-Kadi, Ayman O. S.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2017, 70 (01) : 16 - 24
  • [4] CYP1B1 inhibition attenuates doxorubicin-induced cardiotoxicity through a mid-chain HETEs-dependent mechanism
    Maayah, Zaid H.
    Althurwi, Hassan N.
    Abdelhamid, Ghada
    Lesyk, Gabriela
    Jurasz, Paul
    El-Kadi, Ayman O. S.
    PHARMACOLOGICAL RESEARCH, 2016, 105 : 28 - 43
  • [5] Salvianolic acid B protects cardiomyocytes from angiotensin II-induced hypertrophy via inhibition of PARP-1
    Liu, Min
    Ye, Jiantao
    Gao, Si
    Fang, Wei
    Li, Hong
    Geng, Biao
    Zou, Jian
    Chen, Xi
    Chen, Shaorui
    Zhang, Luankun
    Yue, Zhongbao
    Ma, Yunzi
    Gao, Hui
    Li, Zhuoming
    Liu, Peiqing
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 444 (03) : 346 - 353
  • [6] S-Enantiomer of 19-Hydroxyeicosatetraenoic Acid Preferentially Protects Against Angiotensin II-Induced Cardiac Hypertrophy
    Shoieb, Sherif M.
    El-Kadi, Ayman O. S.
    DRUG METABOLISM AND DISPOSITION, 2018, 46 (08) : 1157 - 1168
  • [7] 19-Hydroxyeicosatetraenoic acid and isoniazid protect against angiotensin II-induced cardiac hypertrophy
    Elkhatali, Samya
    El-Sherbeni, Ahmed A.
    Elshenawy, Osama H.
    Abdelhamid, Ghada
    El-Kadi, Ayman O. S.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2015, 289 (03) : 550 - 559
  • [8] The role of cytochrome P450 1B1 and its associated mid-chain hydroxyeicosatetraenoic acids metabolites in the development of cellular hypertrophy induced by isoproterenol
    El-Kadi, Ayman O. S.
    Maayah, Zaid H.
    FASEB JOURNAL, 2016, 30
  • [9] The role of cytochrome P450 1B1 and its associated mid-chain hydroxyeicosatetraenoic acid metabolites in the development of cardiac hypertrophy induced by isoproterenol
    Maayah, Zaid H.
    Althurwi, Hassan N.
    El-Sherbeni, Ahmed A.
    Abdelhamid, Ghada
    Siraki, Arno G.
    El-Kadi, Ayman O. S.
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2017, 429 (1-2) : 151 - 165
  • [10] 17-(R/S)-hydroxyeicosatetraenoic acid (HETE) induces cardiac hypertrophy through the CYP1B1 in enantioselective manners
    Isse, Fadumo Ahmed
    Alammari, Ahmad H.
    El-Sherbeni, Ahmed A.
    El-Kadi, Ayman O. S.
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2023, 168
12345